Inventor · disambiguated record
Alison Kay Holzer
Also filed as: HOLZER ALISON KAY
7 granted patents·4 pending applications·84 citations·filing 2008–2016
86Inventor score
Top patents by PatentIndex Score
11 records- 0194US8461303B2LOX and LOXL2 inhibitors and uses thereofSMITH VICTORIA·Filed 2008·Granted Jun 11, 2013·30 cites·30 claims
- 0293US8658167B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2012·Granted Feb 25, 2014·19 cites·30 claims
- 0392US9289447B2Chemotherapeutic methods and compositionsSMITH VICTORIA·Filed 2012·Granted Mar 22, 2016·12 cites·14 claims
- 0492US9176139B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2013·Granted Nov 3, 2015·16 cites·60 claims
- 0586US8679485B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisSMITH VICTORIA·Filed 2008·Granted Mar 25, 2014·6 cites·44 claims
- 0676US9107935B2Chemotherapeutic methods and compositionsSMITH VICTORIA·Filed 2010·Granted Aug 18, 2015·1 cites·27 claims
- 0764US10494443B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2016·Granted Dec 3, 2019·0 cites·22 claims
- 0864US2014128284A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 0964US2014349309A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 1058US2012087917A1Lox and loxl2 inhibitors and uses thereofSMITH VICTORIA·Filed 2011·Application pending·0 cites
- 1157US2016185877A1Lox and loxl2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alison Kay Holzer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →